Bcl-XL and Bcl-2 in Cancer Cell Death
Author Information
Author(s): In-Ki Kim, Yong-Ki Jung, Dong-Yun Noh, Yong-Soo Song, Chul-Ho Choi, Byung-Hoon Oh, Masuda E S
Primary Institution: Kwangju Institute of Science and Technology
Hypothesis
Increased expression of Bcl-XL in breast cancer cells inhibits TRAIL-induced apoptosis.
Conclusion
Bcl-XL is significantly upregulated in breast cancer tissues and effectively suppresses TRAIL-induced apoptosis in various tumor cell lines.
Supporting Evidence
- Bcl-XL was found to be upregulated 4-5 fold in breast cancer tissues compared to normal tissues.
- Jurkat32H cells expressing Bcl-XL showed resistance to TRAIL-induced apoptosis.
- Western blot analysis indicated that Bcl-XL expression was significantly higher in cancer tissues than in normal tissues.
Takeaway
This study found that a protein called Bcl-XL helps cancer cells survive by stopping them from dying when treated with a substance that usually kills cancer cells.
Methodology
The study involved functional screening of a cDNA library to isolate genes that inhibit TRAIL-induced apoptosis, followed by various assays including Western blotting and flow cytometry.
Limitations
The study primarily focused on specific cell lines and may not fully represent the complexity of TRAIL responses in all breast cancer types.
Participant Demographics
Patients with infiltrating ductal carcinoma of the breast.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website